Acute Porphyria Drugs

J01DD13 - Cefpodoxime

Probably not porphyrinogenic
PNP

Rationale
The proxetil ester gives rise to cefpodoxime, which is in greater parts excreted in unchanged form. No data pointing to CYP-interaction. Conflicting references.
Chemical description
Perorally administered betalactamase stable cephalosporin administered as proxetil ester, used (up to 200mg x 2) in acute sinusitis, acute otitis media and pharyngotonsillitis where penicillins are ineffective. Hydrolyzed in the intestine to cefpodoxim which is absorbed systematically. Around 80% is excreted in unchanged form in urine. No data pointing to CYP induction.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes J01D / J01DD or go back.
References
# Citation details PubMed ID
Porphyria Drug Lists
1. French List
Centre Français des Porphyries
2. South African List
Porphyria South Africa No longer maintained
Tradenames

Cefpodoxime · Orelox Cefpodoxima Cefodox · Cefpodoxima · Proxedox Forexo Cefpodoxim Orelox Cefodox · Orelox Cefpodoxime Proxetil · Doxcef Orelox Tridox Rexocef Trexodo Forexo Orelox Cefpodoxima Cefpodoxime
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙